Coronary heart disease and thus atherosclerosis is the leading cause of death among patients suffering from diabetes mellitus; men and women with diabetes have a three to fivefold higher coronary heart disease mortality or incidence rate compared with non-diabetic subjects [1] . Although a number of factors such as hyperglycaemia, dyslipidaemia, a procoagulant state, hyperinsulinaemia, glycation of proteins, oxidation or glycation of lipoproteins, as well as enhanced smooth muscle cell proliferation and foam cell formation, have all been suggested as possible links between diabetes and atherosclerosis [1], the increased risk of coronary heart disease among diabetic patients still remains largely unexplained.
is caused by increased insulin production secondary to insulin resistance [7] . Accordingly, it seems to be a very important question for diabetic patients as to whether hyperinsulinaemia in itself is a promotor of atherosclerosis.
The aim of the present study was to address this question experimentally using a well-known animal model for atherosclerosis research: we used the cholesterol-fed rabbit to examine whether subcutaneous injections of insulin resulting in exogenous hyperinsulinaemia promotes atherosclerosis. The rabbits were only fed small amounts of cholesterol, but for an extended period of time, thus maintaining a plasma cholesterol level equivalent to the high human level. Since injection of insulin may affect a number of other factors of importance for atherosclerosis, variation in such factors was taken into account: we measured levels of cholesterol, triglycerides, lipoproteins, insulin, C-peptide, insulin antibodies and glucose in the 'fasting' as well as in the postprandial state throughout the 24-week study period; levels of postheparin plasma lipoprotein lipase and hepatic lipase activities were measured twice.
Materials and methods
Animals and study design. Forty adult female New Zealand White rabbits were assigned to two groups, insulin and placebo, such that the mean body weight was the same (3.00 ± 0.05 kg) in both groups (X ± SEM; range 2.5-3.6 kg). The rabbits were weighed every third week throughout the 24-week experimental period; the mean weight increased steadily in both groups and at week 24, insulin and placebo rabbits weighed 3.95 ± 0.05 and 3.89 ± 0.04 kg, respectively (no significant difference).
For the first 7 weeks, all rabbits were fed daily in the early morning with 100 g rabbit chow (Altromin 2113, Lage, Germany) containing 0.4 % cholesterol (CH-UPS, Sigma, St.Louis, Mo., USA) and 5 % corn oil (Oleum Maidis BP-80, Meco Benzon, Copenhagen, Denmark); during the last 17 weeks the 100 g chow was altered to contain 0.2 % cholesterol and 2.5 % corn oil (cholesterol was dissolved in corn oil at 120°C and subsequently mixed with the chow). Because only 100 g chow was fed daily, all rabbits began eating immediately upon feeding; however, the time when all the chow was eaten varied from rabbit to rabbit. Generally all rabbits finished their meal within 1-2 h after feeding, and there were no observed differences in eating patterns between insulin and placebo rabbits.
About 30 min after receiving chow, the rabbits were daily injected subcutaneously with 6 IU of human insulin (60 m l; 30 % as soluble insulin and 70 % as isophane insulin; Actraphane HM 100 IU/ml, Novo Nordisk, Bagsvaerd, Denmark) or placebo, respectively. In pilot experiments it was determined that the largest injectable amount of insulin before frequent episodes of hypoglycaemia appeared, was 6 IU daily. In spite of this, during the 24-week experiment four rabbits in the insulin group died or were removed from the experiment due to severe hypoglycaemia and two additional rabbits encountered hypoglycaemia once, but were revived by administration of intravenous glucose.
Blood samples of 10-12 ml were drawn from ear veins initially and every third week thereafter; at weeks 3, 9, 15, and 21 blood samples were drawn postprandially 3-4 h after feeding and injection, whereas at weeks 0, 6, 12, 18, and 24 blood samples were drawn in the 'fasting' state, i. e. about 23 h after the last feeding and injection. Additionally, at week 15 blood samples of 4 ml were drawn every 3 h during a 24-h period from ten rabbits in each group.
The experiment was in accordance with Danish regulations for experiments on animals and the 'Principles of laboratory animal care' (NIH publication No. 85-23).
Insulin, C-peptide and glucose. Plasma insulin was measured using an enzyme-immunoassay based on the ELISA principle (Enzymun-Test Insulin; Boehringer Mannheim, Mannheim, Germany). When human and rabbit insulin (Novo Nordisk) were added to plasma samples, 104 ± 1 % (n = 5) and 89 ± 2 % (n = 5) of the added amount of the two types of insulin was recovered with this assay, respectively. C-peptide in plasma was measured with a radioimmunoassay against human C-peptide (RIA Kit for Human C-peptide, Antiserum M1221; Novo Research Institute, Novo Nordisk). When human C-peptide (Novo Nordisk) was added to plasma samples, 83 ± 3 % (n = 4) of the added amount was recovered with this assay. It was not possible to obtain purified rabbit Cpeptide and therefore the levels of C-peptide measured in the rabbits may not be accurate; however, comparison of levels between rabbits is still valid.
Blood glucose was measured with an enzymatic test after blood was mixed with perchloric acid (Glucose 14055, Gluc-DH-Method; Merck System, Darmstadt, Germany). 6 g × h in solvent densities of 1.006, 1.019 and 1.063 g/ml; VLDL particles in these animals are of the beta-VLDL type [8] . Cholesterol (CHOD-PAP, Boehringer Mannheim) was measured in plasma and lipoproteins, and triglycerides (GPO-PAP, Boehringer Mannheim) in plasma.
Lipids and lipoproteins.
Insulin antibodies. The immune response to injection of human insulin into rabbits was measured with a radioimmunoassay to detect rabbit antibodies against human insulin and was kindly performed by Novo Nordisk. The values are expressed as percentage of radioactive insulin bound to antibodies after radioactivities were adjusted based on the radioactivity bound to serum from rabbits not exposed to human insulin.
Lipoprotein lipase and hepatic lipase. At weeks 20 and 22, postheparin plasma lipoprotein lipase and hepatic lipase activities were measured as follows [9, 10] : between 3 and 4 h after the daily meal, blood samples were drawn into disodium EDTA, 10 min after intravenous injections of 200 units of heparin per kg body weight (SAD, Copenhagen, Denmark). Blood and plasma were kept at 4°C before freezing at -80°C until assayed in duplicate Atherosclerosis. At week 24, the rabbits were killed by intravenous injection of 50-100 mg pentobarbital/kg body weight (50 mg/ml). The aorta from the origin at the left ventricle to the common iliac arteries was dissected free, the adventitia carefully removed and the aorta opened longitudinally and rinsed with saline. The vessel was fixed with small pins on a cork board and the surface area outlined on underlying graph paper before being divided into three parts: the aortic arch at the level of the first intercostal arteries, the thoracic aorta at the origin of the coeliac trunk, and the abdominal aorta. Each part was photographed for later estimation of atherosclerosis extent using point counting [12] : the number of points covering intimal lesions was divided by the total number of points covering that arterial segment and the values expressed as percentage of the area covered with lesions. After being photographed, the intima-inner media was stripped from the outer media, each part was weighed and the tissues were stored at −20°C until analysis.
The intima-inner media was minced and the lipids were extracted with chloroform/methanol (1:1, vol/vol) for 24 h. Total cholesterol in the extract was determined by the LibermannBurchard method after saponification [13] ; we had previously shown that separation of aortic total cholesterol into the free and esterified fraction in cholesterol-fed rabbits is not superior to the measurement of total cholesterol alone [14] . The aortic cholesterol content is also closely associated with other indices of atherosclerosis in rabbits and pigs [15, 16] .
Statistical analysis
Statistical analyses were performed with the SPSS [17] or Minitab program [18] . Differences between insulin and placebo rabbits were compared using Student's t-test or Wilcoxon's signed rank procedure. Additionally, univariate and multiple linear regression of the independent variables in the Figures and Table 1 as predictors of atherosclerosis severity in all rabbits were performed simultaneously. To achieve near-normal distribution of variables, plasma insulin, plasma triglycerides, plasma insulin antibodies and cholesterol content in the thoracic and abdominal aorta were transformed logarithmically and cholesterol content in the aortic arch was square root transformed prior to linear regression analysis or Student's ttest. Values are shown as means ± SEM. A p-value of less than 0.05 on two-sided tests was considered statistically significant.
Results
Subcutaneous injection of 6 IU of human insulin (30 % soluble insulin and 70 % isophane insulin) into cholesterol-fed rabbits resulted in exogenous hyperinsulinaemia for up to 16 h after injection (Fig. 1 ). In the 'fasting' state, i. e. 23 h after the last meal and injection, plasma insulin was only marginally higher in insulin injected compared with placebo injected rabbits (Fig. 2) . As ascertained from plasma C-peptide levels, rabbits injected with insulin exhibited depressed endogenous insulin production during the whole 24-h period (Figs. 1, 2 ). Blood glucose was depressed markedly within 3-4 h after insulin injection, but to a large extent was not affected during the remaining part of the day (Figs. 1, 2) ; four rabbits died or were removed from the experiment due to episodes of severe hypoglycaemia.
The postprandial plasma triglyceride response was depressed from 13 to 19 h after the daily meal in rabbits injected with insulin (Figs. 1, 2 ). This depression was not explained by a larger activity of lipoprotein lipase or hepatic lipase in post-heparin plasma in insulin-treated rabbits (Table 1) . Interestingly, the maximal response in plasma triglycerides in placebo rabbits occurred approximately 14 h after the meal, in contrast to humans in whom the maximal response occurs 3-4 h after a fatty meal [19] . Accordingly, the postprandial plasma triglyceride level measured 3-4 h after the meal (Fig. 2) is not representative for plasma triglycerides during the entire postprandial phase (Fig. 1) .
To achieve plasma cholesterol levels in the high human range around 20 mmol/l, rabbits were fed 0.4 g cholesterol daily for the first 7 weeks and 0.2 g thereafter. In spite of the same dietary intake of cholesterol, at some time points insulin-treated rabbits had lower plasma cholesterol levels than placebo rabbits (Fig. 3) . This difference mainly reflected a lower VLDL (i. e. beta-VLDL) cholesterol level in insulintreated rabbits, whereas at most time points plasma levels of IDL, LDL and HDL cholesterol were similar in the two groups, in the 'fasting' as well as the postprandial state (Fig. 3) .
Antibodies against human insulin developed gradually in 8 of 16 rabbits injected with insulin for 24 weeks. The rabbits in the insulin-treated group Individual values of plasma C-peptide below the detections limit where given the value 0 when mean values were calculated. Differences between insulin and placebo rabbits at a given point were tested with Student's t-test: *p < 0.05, **p < 0.01, ***p < 0.001; no asterisk indicates insulin and placebo rabbits did not differ (p > 0.05). To approach normal distribution plasma insulin and triglycerides were transferred logarithmically (log 10 ) before t-tests, but untransformed values are shown. Values are means ± SEM. Individual values of plasma C-peptide below the detections limit where given the value 0 when mean values were calculated. Differences between insulin and placebo rabbits at a given point were tested with Student's t-test: *p < 0.05, **p < 0.01, ***p < 0.001; no asterisk indicates insulin and placebo rabbits did not differ (p > 0.05). To approach normal distribution plasma insulin and triglycerides were transferred logarithmically (log 10 ) before t-tests, but untransformed values are shown.
U
, Insulin (n = 16); k , placebo (n = 20) had higher levels of insulin antibodies on average than the placebo rabbits (Fig. 4) .
When all insulin and placebo rabbits were compared on univariate analysis (Wilcoxon's signed rank procedure), there were no significant differences in extent (% intima with lesions) or severity of atherosclerosis (aortic cholesterol content) between the two groups, in arch, thoracic or in the abdominal aorta (Fig. 5, left panels) . To normalize for differences in plasma cholesterol levels between the two groups, rabbits in the two groups were matched for plasma cholesterol levels leading to two new groups consisting of 15 rabbits with almost identical mean plasma cholesterol levels (Fig. 5, right panels) ; even then, there was still no significant difference in the extent or severity of atherosclerosis in the three aortic sites between the two groups.
On neither univariate nor stepwise multiple linear regression analysis were 'fasting' or postprandial plasma insulin levels a predictor of atherosclerosis severity; the independent variables shown in Figures  2-4 (except total plasma cholesterol) and Table 1 as predictors of the dependent variable of atherosclerosis severity (Fig. 5, lower left panel) were performed on all rabbits combined. In the three aortic sites, the first ranked independent predictor was postprandial IDL cholesterol in the arch, and postprandial plasma triglyceride levels in both the thoracic and abdominal aorta (Table 2) ; in all three sites HDL cholesterol level was the only other independent predictor.
Discussion
One important new observation in the present study is the lack of difference in the extent and severity of atherosclerosis between cholesterol-fed rabbits injected with insulin and placebo, despite hyperinsulinaemia in insulin-treated rabbits for up to 16 h after injection daily for 24 weeks. Previous animal studies [20] [21] [22] [23] have examined the effect of hyperinsulinaemia in models not generally designed to study atherosclerosis, i. e. where there were very low levels of atherogenic lipoproteins. These studies found increased arterial content of lipid [20] , triglycerides [21] [22] [23] , or smooth muscle cells [23] in hyperinsulinaemic animals, however, never showed an increased arterial content of cholesterol or foam cells, hallmarks of early human atherosclerosis [24] ; on the other hand cholesterol deposition and foam cells are characteristics of atherosclerosis in cholesterol-fed rabbits [24] where the abnormal beta-VLDL particle is probably the main cause of atherosclerosis [8] . 
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, Insulin (n = 16); k A Therefore, taken together, the experimental evidence does not suggest a direct role for insulin in promoting atherosclerosis. We chose to study the effect of exogenous hyperinsulinaemia in non-diabetic rather than in diabetic rabbits. Therefore, we only studied the effect of insulin injections, whereas when diabetic, insulin-injected rabbits were compared with non-diabetic rabbits, as in our previous study [25] , the effect of diabetes and insulin injections were studied simultaneously. Insulin injections in that previous study in cholesterol-fed rabbits were also found not to promote atherogenesis, and these rabbits most likely also had exogenous hyperinsulinaemia since they received 3.8 IU of insulin per kg daily compared with 1.7 IU per kg daily in the present study. For comparison, in the University Group Diabetes Program patients with NIDDM in insulin-treated groups received between 0.2 and 0.6 IU of insulin per kg daily [26] (we assumed an average weight of 70 kg for participants), and in the Diabetes Control and Complications Trial patients with IDDM in the conventional therapy group received 0.6-0.7 IU insulin per kg daily [27] . Since we are not aware of reports from these studies on 24-h plasma insulin curves in diabetic patients in response to insulin injections, we were not able to compare directly the level of hyperinsulinaemia in the present study with that in insulin-treated diabetic patients; on average throughout the entire 24-h period, insulin-treated rabbits in the present study had 3.8-fold higher plasma insulin levels compared with placebo-treated rabbits. However, extrapolation from the present data obtained in non-diabetic rabbits to humans, particularly to insulin-treated diabetic patients, requires caution.
The interest in insulin as a cardiovascular risk factor stems originally from three large population studies in Helsinki [28] , Paris [29] and Busselton, Australia [30] , where high insulin levels were shown to be associated with increased incidence and mortality rates of coronary heart disease. Whether this association is causal is still the subject of much debate [3] [4] [5] [6] . Neither insulin injection compared with placebo in patients with NIDDM in the University Group Diabetes Program, nor intensive insulin treatment compared with conventional insulin treatment in patients with IDDM in the Diabetes Control and Complications Trial, led to increased cardiovascular incidence or mortality [26] . These results also do not support the hypothesis that insulin promotes atherosclerosis directly. One possible explanation for these apparently conflicting results is that hyperinsulinaemia is a marker for the insulin resistance syndrome [5] [6] [7] , characterised by a cluster of cardiovascular risk factors such as a degree of glucose intolerance, an increase in plasma triglycerides, a reduction in HDL cholesterol levels, high blood pressure, hyperuricaemia, small dense LDL particles, obesity, and high levels of plasminogen activator inhibitor 1. One or more of these risk factors could be causally related to atherosclerosis and coronary heart disease, and thereby account for the observed association between high insulin levels and coronary heart disease. Another interesting new observation in the present study is that on multivariate analysis postprandial plasma triglycerides and IDL levels were the best independent predictors of atherosclerosis severity; in the postprandial state the IDL fraction contains a mixture of IDL of hepatic origin and chylomicron remnants. It is important to note that postprandial values in this analysis represent values 3-4 h after the meal and not 13-15 h after the meal where plasma triglycerides reached maximal values in placebo rabbits. That postprandial lipoproteins and in particular remnant lipoproteins (IDL, small VLDL, chylomicron remnants) could be important for atherogenesis was originally proposed by Zilversmit [31, 32] . IDL levels have also been found to be strong predictors of atherosclerosis in genetically hyperlipidaemic [33] and cholesterol-or casein-fed rabbits [34] . In humans without major genetic or secondary forms of hyperlipidaemia, IDL and small VLDL have been shown to be independent predictors of the presence, severity, or progression of atherosclerosis [35] [36] [37] [38] [39] . Patients with type III hyperlipoproteinaemia [8] , chronic renal failure [40] or NIDDM [41] have elevated levels of remnant lipoproteins as well as accelerated development of atherosclerosis. Finally, elevated postprandial levels of triglycerides or remnant lipoproteins have also been found to be predictors of the presence, severity, progression or familial risk of atherosclerosis [42] [43] [44] [45] [46] [47] [48] . The present results therefore add to the growing evidence that remnant lipoproteins in the postprandial state may be involved directly in promoting atherosclerosis.
The mechanism by which remnant lipoproteins or smaller triglyceride-rich lipoproteins such as chylomicron remnants and small VLDL and IDL particles could promote atherosclerosis directly, would involve transfer of these particles into the intima [49] [50] , where such particles appear to be retained selectively [50] [51] . In contrast to LDL, smaller triglyceride-rich lipoproteins without prior modification can then be taken up directly by macrophages to produce foam cells [1, 52] , a key cell type of the atherosclerotic plaque [24] . Surprisingly, fasting HDL cholesterol was independently positively associated with aortic cholesterol content at all three aortic sites. This could imply an atherogenic effect of HDL in these animals, which is very different from the supposed anti-atherogenic effect of HDL in humans. However, in cholesterolfed rabbits such as those in the present study only 3-7 % of plasma cholesterol is in the HDL fraction, in contrast to 16-26 % in humans [53] . Accordingly, the cholesterol-fed rabbit may not be a very good model for studying the influence of HDL cholesterol on atherogenesis, at least not if the aim is to mimic the situation in humans.
In summary, exogenous hyperinsulinaemia did not appear to promote atherogenesis in cholesterol-fed rabbits; however, postprandial levels of triglycerides and particles in the IDL range were the best independent predictors of atherosclerosis severity. Stepwise multiple linear regression with the independent variables shown in Figures 2-4 and Table 1 , except total plasma cholesterol, was performed; in each rabbit for each fasting and postprandial variable shown in Figures 2 and 3 the timeaveraged value (area under curve) was used, for insulin antibody levels the time-averaged value including both values from fasting and postprandial blood samples was used, and for lipoprotein lipase and hepatic lipase activities the mean value of the two measurements were used. Only predictors that were independently statistically significant (p < 0.05) were ranked. TG, Plasma triglycerides; Cum.R 2 , cumulative R 2
